New Research Program Investigates All Phases of Sepsis
The Graute-Oppermann-Graduiertenkolleg “PhaSe” has launched a new three-year research initiative at the University of Duisburg-Essen to investigate the biological mechanisms and long-term consequences of sepsis. Graute and Graute Oppermann-Stiftung, the program aims to bridge the gap between foundational laboratory research and clinical application to improve patient outcomes.
- The “PhaSe” program, involving 17 doctoral candidates, focuses on identifying predisposing risk factors, and mitigating post-sepsis recovery challenges.
- The initiative integrates interdisciplinary expertise from the University of Duisburg-Essen and the Ruhr-University Bochum, covering fields from immunology and cardiology to oncology and neurosciences.
- Research efforts aim to refine diagnostic and therapeutic protocols within the healthcare system to address the complex systemic nature of blood poisoning.
Research focus of the PhaSe initiative
The acronym “PhaSe” stands for “Phasenübergreifende Sepsis-Forschung,” or cross-phase sepsis research. The researchers intend to categorize the progression of sepsis into three distinct stages: predisposing factors, the acute disease phase, and long-term sequelae. By studying these phases in an integrated framework, the team seeks to identify why certain individuals experience significantly more severe clinical courses than others.
Collaborative expertise across the Ruhr region
The program uses the combined clinical and scientific resources of the University Alliance Ruhr. The research team includes 17 doctoral students working across seven thematic fields, drawing on the specific strengths of the University Hospital Essen. These areas include immunology, infectiology, cardiovascular medicine, oncology, and translational neurosciences. Professors Nina Babel and Michael Adamzik from Ruhr-University Bochum contribute years of expertise in the diagnostics and therapy of immune system disorders, a critical component in managing the dysregulated host response that characterizes sepsis.
Foundation provides 150,000 euros to sustain research program
The Drs. Graute and Graute Oppermann-Stiftung has provided 150,000 euros to sustain the program over its three-year duration. This foundation has supported interdisciplinary clinical research at the University of Duisburg-Essen since 2018. The funding structure is designed to allow doctoral candidates to step away from their regular medical studies, enabling a concentrated focus on their research projects. Professor Thorsten Brenner noted that the primary goal of this investment is to generate findings that provide long-term benefits to both patients and the broader healthcare system.
Future trajectory of sepsis research
The integration of translational approaches is intended to move beyond theoretical models and into clinical utility. By bundling expertise across multiple medical faculties, the project aims to stimulate new impulses for interdisciplinary research. For patients who have survived the acute phase of sepsis, understanding the persistent immune or neurological impacts remains a significant clinical challenge.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.